Quick answer
ASAP and high-grade PIN are prostate biopsy findings that do not confirm cancer. With ASAP, the pathologist saw suspicious glands without certainty. With high-grade PIN, the cells lining the glands are abnormal.1,2 The European guideline does not ask for a routine repeat biopsy for these findings, because the chance of significant cancer on the repeat biopsy was 6% to 8%.1 The next step is to look at the PSA and the MRI. In my practice, with PI-RADS 3 or higher, I always recommend a biopsy.
What the report means
A biopsy removes thin cores of the prostate, and the pathologist examines each one under the microscope. Most of the time, the report says whether there is cancer. Sometimes it includes one of these two findings:
| Finding | What the pathologist saw |
|---|---|
| ASAP (atypical small acinar proliferation) | A small group of suspicious glands without enough features to confirm cancer2 |
| Focal high-grade PIN | Glands with an abnormal lining in a single core2 |
| Multifocal high-grade PIN | The same change in several cores2 |
ASAP appears in fewer than 5% of biopsies.1 PIN is considered a precursor of cancer, but its effect on the chance of significant cancer is unknown. Low-grade PIN should not even be reported, because it does not help predict cancer.1
When the report says "isolated PIN", it means it appeared without cancer in the other cores. If another core already showed cancer, management follows the cancer.2 I explain the rest of the report in Gleason, ISUP and the biopsy report.
ASAP: the chance of cancer on a repeat biopsy
According to the American guideline, isolated ASAP is linked to cancer in 30% to 50% of repeat biopsies, and about 10% to 20% of these cancers are ISUP grade group 2 or higher, the ones called clinically significant.2
A 2024 review pooled 16 studies with 1,796 men who had ASAP and a repeat biopsy. Significant cancer was found in 12.1% of them.3 Most of these men had their first biopsy without an MRI.2
In a more recent series cited by the European guideline, the chance of significant cancer after ASAP or high-grade PIN was 6% to 8%. That was not very different from what is seen after a negative biopsy, so the guideline does not ask for a routine repeat biopsy.1
High-grade PIN: isolated, focal and multifocal
Older studies, with biopsies of few cores, found a lot of cancer after PIN. With 12 or more cores, the chance of any cancer on a repeat biopsy was 20% to 30%, the same as after a benign biopsy. The chance of ISUP grade group 2 or higher cancer was about 10%.2
The number of cores with PIN used to be seen as a warning sign:
- In a 2004 study, cancer was later found in 22% of men with PIN in a single core and in 35.9% of those with PIN in two or more cores.4
- In a 2006 study, with PIN in four or more cores, cancer was found in 39% of repeat biopsies.5
These studies were done without MRI. In a 2022 Spanish study, 293 men with isolated PIN had an MRI before the repeat biopsy. Among those whose PSA stayed high or whose rectal exam stayed abnormal, 34.7% had significant cancer, similar to men without PIN in the same situation (28.4%). Of the 45 men whose suspicion went away, only one had significant cancer (2.2%).6
That is why the American guideline says the decision to repeat the biopsy after PIN should follow the PSA trend, the rectal exam and the MRI, not the PIN finding alone, even when it is multifocal.2
The role of MRI and targeted biopsy
Multiparametric MRI shows whether there is a suspicious area in the prostate and gives it a score, PI-RADS. After ASAP or PIN, it helps separate men who need a repeat biopsy from those who can keep monitoring.
In a US registry of 207 men with ASAP or multifocal PIN who had a repeat biopsy, the difference was large:7
| MRI before the repeat biopsy | ISUP grade group 2 or higher cancer |
|---|---|
| PI-RADS 4 or 5 | 56% |
| No MRI | 12% |
| PI-RADS 3 or lower | 3% |
The American guideline advises an MRI before any repeat biopsy, if one has not been done. If there is a suspicious lesion, the repeat biopsy takes cores aimed at it and may add systematic cores.2 On a repeat biopsy, leaving out the systematic cores would miss about 10% of significant cancers, according to the European guideline.1
The page on fusion biopsy explains how MRI images guide the needle.
When to repeat the biopsy and how soon
The guidelines handle the two findings a little differently:
| Finding | European guideline (2026) | American guideline (2023, amended 2026) |
|---|---|---|
| ASAP | Routine repeat biopsy not required1 | Further testing, which may include a repeat biopsy2 |
| Focal high-grade PIN | Routine repeat biopsy not required1 | No immediate repeat biopsy2 |
| Multifocal high-grade PIN | Routine repeat biopsy not required1 | Assess risk with PSA, rectal exam and MRI2 |
Further testing after ASAP may include MRI, with or without a targeted biopsy, PSA and blood, urine or tissue tests.2
There is no set interval. The American guideline says there is little evidence on the best time to repeat testing after ASAP.2 In the 2024 review, men who repeated the biopsy within 6 months had significant cancer in 9% of cases, and those who repeated it after 6 months, in 22%. The authors concluded that the repeat biopsy can be safely deferred and that less invasive tests are worth using first.3
In practice, the timing is set by how the PSA, rectal exam and MRI evolve. A suspicious lesion should be discussed promptly. With no lesion and a stable PSA, monitoring continues.1,2
What this changes on the way to treatment
ASAP and high-grade PIN are not treated in themselves. What is treated is cancer, when a biopsy finds it.2
If the repeat biopsy finds cancer, the ISUP grade group, the PSA and the rectal exam define the risk group, as I explain in Gleason, ISUP and the biopsy report. For low-risk cancer, active surveillance is usually the path. For intermediate-risk cancer, we discuss surgery, radiotherapy and, in selected cases, surveillance.
If the repeat biopsy finds no cancer, the page on negative biopsy with a high PSA shows what to look at next.
How I approach it
For ASAP and high-grade PIN, I follow the European guideline. The decision comes from the MRI, the report and the PSA trend, case by case. When no MRI has been done, I order one before talking about a repeat biopsy. With PI-RADS 3 or higher, I always recommend a biopsy.
I have performed transperineal biopsy since 2022, always with sedation, in the operating room and without antibiotics. The procedure takes about 20 minutes. In my practice, MRI fusion is cognitive: with the images at hand, I take cores from the lesion and from the rest of the prostate. Review of the slides by a uropathologist is reserved for specific cases.
My PhD research was on reading prostate slides with artificial intelligence in pathology. The consultation can be at my office in Vila Mariana or online, in English, with your tests sent in advance.
When to see a urologist
- If your biopsy report mentioned ASAP or high-grade PIN
- If you have not had a prostate MRI since that report
- If your PSA keeps rising after the biopsy
- If a new MRI showed PI-RADS 3, 4 or 5
Send your case
If your report mentioned ASAP or high-grade PIN and you would like my opinion before a consultation, fill in the form below. It goes to my office, and you will get a reply within 24 hours by email or WhatsApp. The form does not replace a consultation: it helps plan the next step.
Frequently asked questions
Is ASAP on a prostate biopsy cancer?+
It is not a cancer diagnosis. ASAP means the pathologist saw a small group of suspicious glands without enough features to confirm cancer.2 The finding appears in fewer than 5% of biopsies.1
What is high-grade PIN of the prostate?+
It is a change in the cells lining the prostate glands, considered a precursor of cancer, but its effect on the chance of significant cancer is unknown.1 The report may say whether it is in a single core (focal) or in several (multifocal).2
What is the chance of cancer on a repeat biopsy after ASAP?+
In a review of 16 studies with 1,796 men, 12.1% had significant cancer on the repeat biopsy.3 In a more recent series cited by the European guideline, the chance was 6% to 8%, close to what is seen after a negative biopsy.1
Does high-grade PIN call for another biopsy?+
Not routinely. The European guideline does not ask for a repeat biopsy for this finding.1 The American guideline advises against an immediate repeat biopsy when PIN is in a single core and, for multifocal PIN, deciding based on PSA, rectal exam and MRI.2
Does MRI help decide whether to repeat the biopsy?+
A great deal. In a US registry of 207 men with ASAP or multifocal PIN, 56% of those with a PI-RADS 4 or 5 lesion on MRI had significant cancer on the repeat biopsy, compared with 3% of those with PI-RADS 3 or lower.7 The American guideline advises an MRI before any repeat biopsy.2
How soon should I repeat the biopsy?+
There is no fixed interval. The American guideline says there is little evidence on the best timing after ASAP.2 The decision depends on how the PSA, rectal exam and MRI evolve, and a suspicious lesion should be discussed promptly.1,2
Who performs prostate biopsy after ASAP or PIN in São Paulo?+
I perform transperineal prostate biopsy in São Paulo, including for men who had ASAP or high-grade PIN on a previous biopsy. I am Dr. Petronio Melo, a urologist and robotic surgeon, CRM-SP 157.598 and RQE 70.275. I hold a PhD from the University of São Paulo Medical School, with award-winning research on artificial intelligence in prostate cancer diagnosis, and I have performed more than 1,500 robotic and laparoscopic surgeries, more than 500 of them robotic. I have performed transperineal biopsy since 2022, always with sedation. My office is in Vila Mariana, and the first consultation can be in person or online, in English.
References
- EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer: diagnostic evaluation. European Association of Urology; 2026. EAU
- Wei JT, Barocas D, Carlsson S, et al. Early Detection of Prostate Cancer: AUA/SUO Guideline (2023, amended 2026). American Urological Association; 2026. AUA
- Ji WT, Jin XF, Wang Y. The Rate of Clinically Significant Prostate Cancer on Repeat Biopsy after a Diagnosis of Atypical Small Acinar Proliferation: A Systematic Review and Meta-Analysis. Oncology. 2024;102(7):631-640. PubMed
- Bishara T, Ramnani DM, Epstein JI. High-grade prostatic intraepithelial neoplasia on needle biopsy: risk of cancer on repeat biopsy related to number of involved cores and morphologic pattern. Am J Surg Pathol. 2004;28(5):629-633. PubMed
- Netto GJ, Epstein JI. Widespread high-grade prostatic intraepithelial neoplasia on prostatic needle biopsy: a significant likelihood of subsequently diagnosed adenocarcinoma. Am J Surg Pathol. 2006;30(9):1184-1188. PubMed
- Morote J, Schwartzmann I, Celma A, et al. The current recommendation for the management of isolated high-grade prostatic intraepithelial neoplasia. BJU Int. 2022;129(5):627-633. PubMed
- Sessine MS, Radoiu CS, Qi J, et al. Can MRI Help Inform Which Men With a History of Multifocal High-Grade Prostatic Intraepithelial Neoplasia or Atypical Small Acinar Proliferation Remain at an Elevated Risk for Clinically Significant Prostate Cancer? J Urol. 2024;211(2):234-240. PubMed
Would you like to talk about your case?
In the consultation, I go over your tests and your priorities.
Book a consultation5.0186 Google reviews
